Rekambys plus Vocabria authorised to treat HIV-1 infections in adults who are virologically suppressed More: EU nod for first long-acting HIV injectable treatment Source: News
read moreMurepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis More: MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic Source: News
read moreNew medicine tezepelumab is being studied in severe asthma More: AZ, Amgen’s SOURCE trial misses primary endpoint Source: News
read moreFollows positive opinion issued by EMA’s CHMP More: Pfizer, BioNTech win EU authorisation for COVID-19 vaccine Comirnaty Source: News
read moreMyovant scores FDA nod for Orgovyx, a first-in-class pill for advanced prostate cancer esagonowsky Mon, 12/21/2020 – 11:31 More: Myovant scores FDA nod for Orgovyx, a first-in-class pill for advanced prostate cancer Source: fierce
read moreWuXi lays out €150M to take over Bayer plant in Germany, boosting pandemic supply network fkansteiner Mon, 12/21/2020 – 11:29 More: WuXi lays out €150M to take over Bayer plant in Germany, boosting pandemic supply network Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals